Delix Therapeutics, a clinical-stage neuroscience company pioneering novel neuroplasticity-promoting treatments for psychiatric and neurological disorders, today announced that the first patient has ...
The global schizophrenia drug market size was US$ 7.9 billion in 2021. The global schizophrenia drug market is forecast to grow to US$ 9.8 billion by 2030, registering a compound annual growth rate ...